Terbequinil

This classification denotes an antipsychotic agent with the molecular formula C15H18N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0DH9WUS03O, chemically known as 1,4-dihydro-1-(methoxymethyl)-4-oxo-n-propyl-3-quinolinecarboxamide but generally known as terbequinil, which bears US NIH Compound Identifier 65916. European Medicines Agency schedules Terbequinil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10908MIG. The term TERBEQUINIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). TERBEQUINIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule terbequinil under HS 29334990 and SITC 51575. As of Q4 2014, TERBEQUINIL remains the US FDA Preferred Term for this commodity. Terbequinil bears US NLM identifiers UMLS ID C2348661 and NCI Concept Code C73243. SMILES: O(CN1C2C(C(=O)C(C1)C(=O)NCCC)CCCC2)C.